Chengdu Institute of Biological Products Co., Ltd. (hereinafter referred to as "the Company") is a wholly-owned subsidiary of China Biotechnology Co., Ltd., a Fortune Global 500 enterprise managed by the State owned Assets Supervision and Administration Commission of the State Council and the largest pharmaceutical industry group in China. It is a national high-tech enterprise.